VAERS reports by lot

Merck Pneumococcal lot T034630: VAERS reports

24 VAERS reports list lot T034630 as a Merck Pneumococcal vaccine, received between 2021-05-17 and 2022-11-23. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
24
Reports
0%
Marked serious
0
With a death outcome
10
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction2034%
General / Systemic (non-local)1525%
Cardiac / Cardiovascular610%
Musculoskeletal610%
Neurological47%
Allergic / Anaphylactic47%
Gastrointestinal23%
Dermatological (non-injection-site)12%
Psychiatric / Neuropsychiatric12%

Where reports came from

U.S. state of the reporter, where given (top 12).

Idaho3
Texas2
Tennessee2
Ohio1
Oregon1
Massachusetts1
Pennsylvania1
South Carolina1
Minnesota1
Colorado1
Arizona1
Illinois1

Reports by month received

2021-052
2021-065
2021-076
2021-082
2021-091
2022-041
2022-051
2022-081
2022-094
2022-111

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.